Regulatory Mechanisms Governing BubR1 Protein Stability During Stress and Aging
压力和衰老过程中 BubR1 蛋白稳定性的调控机制
基本信息
- 批准号:10624953
- 负责人:
- 金额:$ 29.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcetylationAcetyltransferaseAgeAgingAneuploidyAnimalsBindingBiologicalCHEK1 geneCREBBP geneCell AgingCell SurvivalCell physiologyCellular StressCullin ProteinsCyclin D1DeacetylaseDiseaseEnsureF Box DomainFibroblastsGeneticGenome StabilityGenomic InstabilityGlucoseGoalsHealthHumanIn VitroLinkLongevityLysineMalignant NeoplasmsMammalsMediatingMitosisMitoticMolecularMusMutationNutrientPathologyPathway interactionsPhysiologicalPost-Translational RegulationPremature aging syndromeProcessProtein AcetylationProteinsProteomeProteomicsRegulationRoleSignal PathwaySignal TransductionSignaling ProteinStressTestingTherapeuticTissuesTumor Suppressor ProteinsUbiquitinUbiquitinationage relatedageddeprivationdetection of nutrientdruggable targetgenome integrityhealthspanin vivo Modelmouse modelneoplastic cellnovel therapeutic interventionnutrient deprivationpreventprotein degradationresponsesegregationsenescencetumor progressiontumorigenesisubiquitin-protein ligase
项目摘要
Abstract:
BubR1 is a key regulator of aging through suppressing cellular senescence and is a critical tumor suppressor
through its role in maintaining genome integrity by sustaining fidelity in chromosomal segregation during
mitosis through control of the spindle assembly checkpoint. Importantly, BubR1 levels decline with age putting
it at the intersection of aging and age-related diseases such as cancer. Loss of BubR1 with age is attributed, in
part, through its increased ubiquitin-proteasomal mediated degradation, which can be blocked by increasing
the activity of the NAD+-dependent deacetylase SIRT2. However, the E3 ubiquitin ligase(s) involved in
promoting the decline in BubR1 with age and under conditions of stress remain elusive.
We identified the Skp1-Cullin-F-box (SCF) E3 ubiquitin ligase substrate recognition subunit -TRCP1
as an interactor of BubR1, which targets BubR1 for ubiquitination and degradation. BubR1 contains a putative
binding domain for -TRCP1 (known as a degron motif), which lies adjacent to the acetylated lysine controlled
by SIRT2 suggesting a cross talk between SIRT2-regulated acetylation and ubiquitination of BubR1 by -
TRCP1. Furthermore, -TRCP1 is involved in ubiquitination and degradation of key regulators of genome
stability and cancer such as CHK1 and Cyclin D1 in response to cellular stress, including nutrient deprivation.
Similarly, BubR1 protein levels are destabilized in response to glucose deprivation, suggesting a putative role
for -TRCP1 in regulating BubR1 under physiological stress conditions as well as during the natural aging
process. Based on these observations, we hypothesize that -TRCP1 is a key regulator of BubR1 protein
stability to control aging and disease.
To test this hypothesis, we developed two specific aims. In aim 1 we will define the posttranslational
regulation of BubR1 by -TRCP1 at the molecular level, and its impact on cellular senescence and organismal
lifespan. These studies will investigate the upstream and downstream pathways by which -TRCP regulates
BubR1 protein stability, and its involvement in the promoting the decline of BubR1 with age. In aim 2 we will
determine the role of -TRCP1-mediated protein degradation of BubR1 under conditions of cellular stress
including glucose deprivation by delineating the molecular mechanisms linking cellular sensing of nutrient
stress to ubiquitin-proteasomal mediated degradation of BubR1. In addition, we will assess the consequences
of altering BubR1 and other regulators of genome stability in the cellular response to glucose restrictive
conditions. Finally, we will elucidate the role of -TRCP1 in proteome remodeling during the cellular response
to glucose restriction conditions using an unbiased proteomics-based interaction screen. The overall goal of
this proposal is to elucidate at the molecular and cellular level the role of -TRCP in controlling key regulators
of genomic stability including BubR1 during cellular stress in aging and disease, which will provide the impetus
to develop novel therapeutic interventions for aging and age-related diseases through stabilization of BubR1.
摘要:
BubR 1是通过抑制细胞衰老的关键调节因子,并且是关键的肿瘤抑制因子
通过其在维持染色体分离中的保真度来维持基因组完整性的作用,
通过控制纺锤体组装检查点来控制有丝分裂。重要的是,BubR 1水平随着年龄的增长而下降
它处于衰老和与年龄有关的疾病(如癌症)的交叉点。BubR 1随着年龄的增长而丢失,
部分,通过其增加的泛素-蛋白酶体介导的降解,这可以通过增加
NAD+依赖性脱乙酰酶SIRT 2的活性。然而,E3泛素连接酶参与了
促进BubR 1随年龄和在压力条件下的下降仍然难以捉摸。
我们鉴定了Skp 1-Cullin-F-box(SCF)E3泛素连接酶底物识别亚基-TRCP 1
作为BubR 1的相互作用物,其靶向BubR 1进行泛素化和降解。BubR 1含有一个假定的
与乙酰化赖氨酸控制的结合结构域(称为降解决定子基序)相邻
通过SIRT 2表明SIRT 2调节的乙酰化和BubR 1的泛素化之间的串扰,
TRCP 1。此外,TRCP 1还参与基因组关键调控因子的泛素化和降解
稳定性和癌症,如CHK 1和细胞周期蛋白D1响应细胞应激,包括营养缺乏。
类似地,BubR 1蛋白水平在葡萄糖剥夺反应中不稳定,这表明BubR 1蛋白在葡萄糖缺乏反应中可能起作用。
在生理应激条件下以及在自然衰老过程中,
过程基于这些观察结果,我们假设BubR 1蛋白的一个关键调节因子是TRCP 1,
控制衰老和疾病的稳定性。
为了验证这一假设,我们制定了两个具体目标。在目标1中,我们将定义翻译后
BubR 1在分子水平上的调节,及其对细胞衰老和生物体的影响
寿命这些研究将调查的上游和下游途径,通过该途径,
BubR 1蛋白的稳定性,及其参与促进BubR 1随年龄的下降。在目标2中,
确定在细胞应激条件下BubR 1的Bub-TRCP 1介导的蛋白质降解的作用
包括葡萄糖剥夺,通过描绘连接细胞对营养物质的感知的分子机制,
应激对泛素-蛋白酶体介导BubR 1降解的影响。另外,我们会评估
改变BubR 1和其他基因组稳定性调节因子,
条件最后,我们将阐明在细胞反应过程中的蛋白质组重塑中的作用,
葡萄糖限制条件使用一个公正的蛋白质组学为基础的相互作用屏幕。的总目标
本研究拟在分子和细胞水平上阐明β-TRCP在控制关键调控因子中的作用
包括BubR 1在内的基因组稳定性在衰老和疾病的细胞应激期间,这将提供动力
通过稳定BubR 1来开发针对衰老和年龄相关疾病的新型治疗干预措施。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian J. North其他文献
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities
癌症干细胞中的 E3 泛素连接酶:癌症标志和新治疗机会的关键调节因子
- DOI:
10.1007/s13402-023-00777-x - 发表时间:
2023 - 期刊:
- 影响因子:6.6
- 作者:
Qiang Zou;Meng Liu;Kewei Liu;Yi Zhang;Brian J. North;Bin Wang - 通讯作者:
Bin Wang
Measurement of mammalian histone deacetylase activity.
哺乳动物组蛋白脱乙酰酶活性的测量。
- DOI:
10.1016/s0076-6879(03)77010-4 - 发表时间:
2004 - 期刊:
- 影响因子:0
- 作者:
E. Verdin;F. Dequiedt;W. Fischle;Roy A. Frye;Brett L Marshall;Brian J. North - 通讯作者:
Brian J. North
Conclusions and Research Perspectives
结论和研究观点
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Pengda Liu;Brian J. North;H. Inuzuka;Wenyi Wei - 通讯作者:
Wenyi Wei
The Class III Protein Deacetylases
III 类蛋白质脱乙酰酶
- DOI:
10.1385/1-59745-024-3:237 - 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
B. Schwer;Brian J. North;N. Ahuja;Brett L Marshall;E. Verdin - 通讯作者:
E. Verdin
Brian J. North的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian J. North', 18)}}的其他基金
Regulatory Mechanisms Governing BubR1 Protein Stability During Stress and Aging
压力和衰老过程中 BubR1 蛋白稳定性的调控机制
- 批准号:
10419290 - 财政年份:2022
- 资助金额:
$ 29.83万 - 项目类别:
Characterizing upstream regulators of glucosylceramide metabolism for Parkinson's disease and Lewy Body Dementia
帕金森病和路易体痴呆的葡萄糖神经酰胺代谢上游调节因子的特征
- 批准号:
10323690 - 财政年份:2021
- 资助金额:
$ 29.83万 - 项目类别:
Mechanisms Controlling BubR1 Regulation of Cancer and Aging
BubR1 调节癌症和衰老的控制机制
- 批准号:
9353713 - 财政年份:2016
- 资助金额:
$ 29.83万 - 项目类别:
Mechanisms Controlling BubR1 Regulation of Cancer and Aging
BubR1 调节癌症和衰老的控制机制
- 批准号:
9897456 - 财政年份:2016
- 资助金额:
$ 29.83万 - 项目类别:
Mechanisms Controlling BubR1 Regulation of Cancer and Aging
BubR1 调节癌症和衰老的控制机制
- 批准号:
9180131 - 财政年份:2016
- 资助金额:
$ 29.83万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 29.83万 - 项目类别: